GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Longduoduo Co LDDD · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Longduoduo Co

From its filings with the US Securities and Exchange Commission

SEC filings

Longduoduo Co is based in Hohhot and is incorporated in Nevada. Its shares trade on OTC under the ticker LDDD. The SEC classifies its business as health services. In the fiscal year to 30 June 2026, it reported revenue of $1.8m and a net loss of $578,631. At that date it held total assets of $2.1m and shareholders' equity of $703,691.

In its own words

Longduoduo initiated operations on October 26, 2021, when it issued 30,000,000 shares of its common stock to the shareholders of Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”) in exchange for 100% of the outstanding shares of Longduoduo HK, which at that time owned the Chinese limited companies. Subsequently, LDD Technology Limited and LDDJK Hong Kong Limited replaced Longduoduo HK as the intermediaries to the Chinese limited companies. On August 28, 2026, Longduoduo HK was officially deregistered.

Pursuant to the Holding Foreign Companies Accountable Act (“HFCAA”), as adopted by the United States Congress in 2020, the Public Company Accounting Oversight Board (the “PCAOB”) issued a Determination Report on December 16, 2021 which found that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in the PRC because of a position taken by one or more authorities in mainland China. Under the HFCAA (as amended by the Consolidated Appropriations Act – 2023), an issuer’s securities may be prohibited from trading on a U.S. stock exchange or facility if its auditor is not inspected by the PCAOB for two consecutive years (reduced by Congress in 2023 from three consecutive years in the original HFCAA).

Quoted from its 10-K, filed 30 Sept 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
17 Aug 2022
Head office
G3-5-8016, SHUI'AN TOWN, RUYI HEADQUARTE, HOHHOT, 010000
Incorporated in
NV
Classification
Services-Health Services
Filer status
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Huibo XuChairman of the Board, President, since 2023
  • Ms. Hongxiao ZhouChief Executive Officer, Director$38,218
  • Ms. Liping KangChief Financial Officer
  • Mr. Shan BoIndependent Director
  • Ms. Jiayang MaIndependent Director
  • Ms. Binbin WuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Longduoduo Co Ltd provides preventive care for myocardial infarction and cerebral infarction in China.
  • The company focuses on cardiovascular and cerebrovascular disease prevention services in Hohhot.
  • Longduoduo offers health products and medical examinations through third-party providers.

Weaknesses

  • Longduoduo's business is limited to domestic market in China.
  • The company's services are focused on specific health conditions only.
  • Longduoduo's IPO was on 17 August 2022, a recent listing.

Opportunities

  • Longduoduo can expand preventive care services to other Chinese cities.
  • The company may partner with more third-party healthcare providers in China.
  • Longduoduo could develop new health products for cardiovascular prevention.

Threats

  • Longduoduo faces competition from other health care providers in China.
  • The company's focus on specific diseases may limit market growth.
  • Longduoduo's domestic market reliance increases vulnerability to local regulations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.